Boehringer Ingelheim

Boehringer Ingelheim's investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial. Ingelheim, Germany, Wed, 28/01/2026 - ...

Fierce Biotech

Boehringer shared more phase 2 data on its kidney disease candidate, shedding light on the decision to start a pivotal trial of the prospect.

Stylist

New research has identified a diet that could help to keep our kidneys functioning effectively. We spoke to a nutritionist about how you can ...

Medizinische Hochschule Hannover

MHH nephrologists find cells that provide information about the function of the kidney transplant after rejection.

News-Medical

Large-scale UK Biobank data show that the EAT-Lancet planetary health diet is associated with lower CKD risk, with genetics, green space, and ...

Docwire News

Nephrology news includes xenotransplantation as bridge therapy, a US record for kidney transplants, and a biotech partnership to develop ...

pharmaphorum

Boehringer's TRPC6 inhibitor apecotrep, formerly developed for COVID-19, has shown efficacy in the rare kidney disease FSGS in a phase 2 trial.

Nature

Furthermore, mental health conditions, including depression, bipolar disorder and schizophrenia, increase the risk of developing chronic kidney ...

Time Magazine

blood sugar 7.1 fasting nutrition and follow a kidney healthy diet to avoid complications.In this video, Registered Dietitian Nutritionist Val ...

BBC

Cumbria Police said those taking the Class B drug were suffering with bladder function problems and kidney issues. Officers raided eight addresses ...